Osteoboost Blog | Insights on Bone Health and Innovation

Empowering Women to Take Control of Their Bone Health: Osteoboost Launches Nationwide

Osteoboost, the first FDA-cleared device for osteopenia, is now available nationwide—helping women reduce bone loss with 30 minutes of daily use.

GLP-1 Medications and Low Bone Density: What You Need to Know to Protect Your Bones

GLP-1 drugs like Ozempic may reduce bone density. Learn how to protect your bones while on GLP-1s with exercise, nutrition, and new therapies.

Approval Through FDA’s De Novo Pathway: A Major Accomplishment!

Osteoboost earns rare FDA De Novo approval. Learn what it means, how it differs from 510(k) and PMA, and why it matters for low bone density care.

Addressing Disparities in Osteoporosis Care and Outcomes for Black Americans

Osteoporosis is underdiagnosed in Black Americans. Learn why—and what steps we can take to close the gap in screening, treatment, and outcomes.

Our latest press releases and news

Stay informed with the latest press releases, company announcements, and behind-the-scenes insights from the Osteoboost team.

Osteoboost Presents Clinical Trial Data Demonstrating High Adherence and Usability for Osteopenia at ENDO 2025

A 12-month randomized, sham-controlled clinical trial has found that Osteoboost, the first and only FDA-cleared prescription medical device for low...

Osteoboost Health Launches FDA-Cleared Prescription Wearable Device for Low Bone Density, Filling Critical Treatment Gap for 60M+ Americans

Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for...

Osteoboost Health, Inc. Awarded 6th U.S. Patent for Osteoboost, a Wearable Device for Bone Density Improvement

Osteoboost Health Inc. today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 12,232,993 for...

Osteoboost in the headlines

Explore media highlights and articles featuring Osteoboost’s impact and innovation.

You Can Now Wear This Belt to Help Prevent Osteoporosis

KTLA covers Osteoboost, the FDA‑cleared wearable belt using vibration therapy to strengthen bones and help prevent osteoporosis in postmenopausal women.

This New Wearable Uses NASA Technology to Reverse Bone Loss

Oprah Daily spotlights Osteoboost, an FDA-cleared wearable using NASA-inspired tech to combat bone loss in postmenopausal women.

Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment

Endocrine News spotlights Osteoboost, the first FDA-cleared wearable delivering targeted vibration therapy to slow bone loss in postmenopausal women.